How does diffuse large B-cell lymphoma typically present compared to follicular lymphoma?

Prepare for the NBME Form 29 Test. Study with interactive flashcards and detailed multiple-choice questions, each with explanations and tips. Achieve success on your exam!

Multiple Choice

How does diffuse large B-cell lymphoma typically present compared to follicular lymphoma?

Explanation:
Diffuse large B-cell lymphoma (DLBCL) is characterized by a more aggressive growth pattern compared to follicular lymphoma, which is typically more indolent. The aggressive nature of DLBCL often results in the presentation of symptoms that can be severe and require prompt medical intervention. Patients may experience rapidly enlarging lymph nodes, systemic symptoms such as fever, night sweats, and weight loss, commonly referred to as 'B symptoms,' and potentially involve extranodal sites early in the disease. In contrast, follicular lymphoma often presents as a slower-growing mass and may not be symptomatic in its early stages. It is generally considered to be a low-grade non-Hodgkin lymphoma, and while it can transform into a more aggressive form, initially, it can be managed more conservatively. The statement relating to kappa light chain restriction pertains to immunophenotyping findings that can be associated with various types of B-cell lymphomas, including both DLBCL and follicular lymphoma, and does not distinguish between their typical clinical presentations. Therefore, the emphasis on the aggressive symptoms seen in DLBCL is key to understanding the urgent treatment needs associated with this lymphoma when compared to the more indolent nature of follicular lymphoma.

Diffuse large B-cell lymphoma (DLBCL) is characterized by a more aggressive growth pattern compared to follicular lymphoma, which is typically more indolent. The aggressive nature of DLBCL often results in the presentation of symptoms that can be severe and require prompt medical intervention. Patients may experience rapidly enlarging lymph nodes, systemic symptoms such as fever, night sweats, and weight loss, commonly referred to as 'B symptoms,' and potentially involve extranodal sites early in the disease.

In contrast, follicular lymphoma often presents as a slower-growing mass and may not be symptomatic in its early stages. It is generally considered to be a low-grade non-Hodgkin lymphoma, and while it can transform into a more aggressive form, initially, it can be managed more conservatively.

The statement relating to kappa light chain restriction pertains to immunophenotyping findings that can be associated with various types of B-cell lymphomas, including both DLBCL and follicular lymphoma, and does not distinguish between their typical clinical presentations. Therefore, the emphasis on the aggressive symptoms seen in DLBCL is key to understanding the urgent treatment needs associated with this lymphoma when compared to the more indolent nature of follicular lymphoma.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy